PF 3716556 is a potent and selective P-CAB (potassium-competitive acid blocker), with pIC50 of 6.026 and 7.095 for the inhibition of porcine H+,K+-ATPase activity in ion-leaky and ion-tight assay, respectively, inhibits gastric acid secretion, displays no activity at Na+,K+-ATPase, used for the treatment of gastroesophageal reflux disease. A highly selective H+,K+-ATPase inhibitor that is more potent in acidic conditions.
사양
동의어
8-[[(4R)-3,4-Dihydro-5-methyl-2H-1- benzopyran-4-yl]amino]-N-(2-hydroxyethyl)-N,2-dimethyl-imidazo[1,2-a]pyridine-6-carboxamide | PF03716556 | PF-03716556 | Imidazo(1,2-a)pyridine-6-carboxamide, 8-(((4R)-3,4-dihydro-5-methyl-2H-1-benzopyran-4-yl)amino)-N-(2-hydroxyethyl)-N,2-dimethyl- | N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3, Show more
사양 및 순도
≥98%
생화학 및 생리적 메커니즘
H+,K+-ATPase inhibitor (pIC50= 6 in human recombinant ion-leaky assays); more potent in acidic conditions. Highly selective for H+,K+-ATPasein vitro; displays no activity at Na+,K+-ATPase. Also displays selectivity for H+,K+-ATPase over a range of 50 receptors and ion channels (IC50> 10μM). Inhibits gastric acid secretion in rat and dog models.
This compound belongs to the class of organic compounds known as 1-benzopyrans. These are organic aromatic compounds that 1-benzopyran, a bicyclic compound made up of a benzene ring fused to a pyran, so that the oxygen atom is at the 1-position.
External Descriptors
Not available
1. Djoumbou Feunang Y, Eisner R, Knox C, Chepelev L, Hastings J, Owen G, Fahy E, Steinbeck C, Subramanian S, Bolton E, Greiner R, and Wishart DS. ClassyFire: Automated Chemical Classification With A Comprehensive, Computable Taxonomy. Journal of Cheminformatics, 2016, 8:61.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.